Navigation Links
Two Laser Balloon 'Live Cases' Shed New Light on Direct Visualization and PV Ablation
Date:1/24/2011

MARLBOROUGH, Mass., Jan. 24, 2011 /PRNewswire/ -- CardioFocus announced that two "live cases" using its Endoscopic Ablation System were recently conducted. The first live case was a satellite transmission performed at Centro Cardiologico Monzino in Milan, Italy; broadcast to the 16th Annual Boston Symposium on Atrial Fibrillation in Boston, MA. Several pioneers in the treatment of atrial fibrillation served as moderators for this exciting educational presentation, providing perspective on ablation procedures designed to isolate pulmonary veins.

The second live case was performed at St. Georg Hospital, in Hamburg, Germany, by Prof. Karl-Heinz Kuck. Both cases demonstrate the continued interest of leading catheter ablation experts to gain a real time view of the anatomy they are treating to enable durable PV isolation.

Stephen Sagon, CEO of CardioFocus said, "These back-to-back live cases provide CardioFocus with a unique opportunity to be seen by clinicians from around the world. Now that we have CE Mark approval for the latest version of our equipment, we have received requests from multiple, well-respected international arrhythmia centers. We plan to continue our highly disciplined launch of the Endoscopic Ablation System at key European sites in 2011."

The acute isolation rate of pulmonary veins has been reported by CardioFocus clinical investigators at over 99% in peer reviewed articles. While nearly all of the pulmonary veins were isolated during the procedure, 78% of veins were isolated on the very first attempt. Chronic PV isolation was reported to approach 90% when assessed at 3 months. According to Burke Barrett, CardioFocus Vice President of Clinical and Regulatory Affairs, "We expect more scientific studies and further presentations on our Endoscopic Ablation System technology throughout the year, including the  company's US IDE pivotal study in the first half of 2011."

Two years after the initiation of clinical research, approximately 250 patients have been treated under multiple research protocols at 16 different medical centers world-wide. More than 150 patients were treated in the EU and almost 100 patients were enrolled in a US feasibility clinical trial.

The information in this news release related to our product is preliminary and investigative. The CardioFocus System is not approved by the FDA, and no conclusions can or should be drawn regarding its safety or effectiveness.CONTACT: CardioFocus, Marlborough MA, USAMaria Shepherd +1 (617) 548-9892 (media)
'/>"/>

SOURCE CardioFocus
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Philadelphias Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients
2. Advanced Laser Therapy Solutions for Womens Hair Loss
3. PhotoMedex Launches New Patient-Focused XTRAC Laser Website
4. Alma Lasers Introduces Soprano(XLi) Next Generation Diode Laser Technology
5. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
6. Alma Lasers Joins the Fight Against Breast Cancer with the Launch of the NEW SopranoXLi
7. Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
8. Medical Website Design Experts Aurora Information Technology Introduces Its Newest Website Launch, Muscat Eye Laser Center
9. Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
10. Chula Vistas Dr. Peter Rullan Adds Alma Lasers Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients
11. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):